• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳离子放射治疗中肿瘤的临床氧增强比:局部氧合变化的影响

Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes.

作者信息

Antonovic Laura, Lindblom Emely, Dasu Alexandru, Bassler Niels, Furusawa Yoshiya, Toma-Dasu Iuliana

机构信息

Department of Physics, Stockholm University, Stockholm, Sweden

Department of Physics, Stockholm University, Stockholm, Sweden.

出版信息

J Radiat Res. 2014 Sep;55(5):902-11. doi: 10.1093/jrr/rru020. Epub 2014 Apr 11.

DOI:10.1093/jrr/rru020
PMID:24728013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4240637/
Abstract

The effect of carbon ion radiotherapy on hypoxic tumors has recently been questioned because of low linear energy transfer (LET) values in the spread-out Bragg peak (SOBP). The aim of this study was to investigate the role of hypoxia and local oxygenation changes (LOCs) in fractionated carbon ion radiotherapy. Three-dimensional tumors with hypoxic subvolumes were simulated assuming interfraction LOCs. Different fractionations were applied using a clinically relevant treatment plan with a known LET distribution. The surviving fraction was calculated, taking oxygen tension, dose and LET into account, using the repairable-conditionally repairable (RCR) damage model with parameters for human salivary gland tumor cells. The clinical oxygen enhancement ratio (OER) was defined as the ratio of doses required for a tumor control probability of 50% for hypoxic and well-oxygenated tumors. The resulting OER was well above unity for all fractionations. For the hypoxic tumor, the tumor control probability was considerably higher if LOCs were assumed, rather than static oxygenation. The beneficial effect of LOCs increased with the number of fractions. However, for very low fraction doses, the improvement related to LOCs did not compensate for the increase in total dose required for tumor control. In conclusion, our results suggest that hypoxia can influence the outcome of carbon ion radiotherapy because of the non-negligible oxygen effect at the low LETs in the SOBP. However, if LOCs occur, a relatively high level of tumor control probability is achievable with a large range of fractionation schedules for tumors with hypoxic subvolumes, but both hyperfractionation and hypofractionation should be pursued with caution.

摘要

由于扩展布拉格峰(SOBP)中的线性能量传递(LET)值较低,碳离子放射治疗对缺氧肿瘤的效果最近受到质疑。本研究的目的是探讨缺氧和局部氧合变化(LOCs)在分次碳离子放射治疗中的作用。假设分次间存在LOCs,模拟了具有缺氧子体积的三维肿瘤。使用具有已知LET分布的临床相关治疗计划应用不同的分割方式。考虑到氧张力、剂量和LET,使用具有人类唾液腺肿瘤细胞参数的可修复-条件可修复(RCR)损伤模型计算存活分数。临床氧增强比(OER)定义为缺氧和氧合良好的肿瘤达到50%肿瘤控制概率所需剂量的比值。所有分割方式得到的OER均远高于1。对于缺氧肿瘤,如果假设存在LOCs而不是静态氧合,则肿瘤控制概率会显著更高。LOCs的有益效果随着分割次数的增加而增加。然而,对于非常低的分割剂量,与LOCs相关的改善并不能弥补肿瘤控制所需总剂量的增加。总之,我们的结果表明,由于SOBP中低LET下不可忽略的氧效应,缺氧会影响碳离子放射治疗的结果。然而,如果发生LOCs,对于具有缺氧子体积的肿瘤,在大范围的分割方案下可以实现相对较高水平的肿瘤控制概率,但超分割和低分割都应谨慎采用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/dfba45cc4dc0/rru02008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/86eb185b3162/rru02001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/594d2230bccc/rru02002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/9bf10b16d8fd/rru02003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/2feea667fa7d/rru02004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/da6c4092beba/rru02005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/733f4b4fd56e/rru02006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/9cf4984e1ac6/rru02007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/dfba45cc4dc0/rru02008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/86eb185b3162/rru02001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/594d2230bccc/rru02002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/9bf10b16d8fd/rru02003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/2feea667fa7d/rru02004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/da6c4092beba/rru02005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/733f4b4fd56e/rru02006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/9cf4984e1ac6/rru02007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/942d/4240637/dfba45cc4dc0/rru02008.jpg

相似文献

1
Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes.碳离子放射治疗中肿瘤的临床氧增强比:局部氧合变化的影响
J Radiat Res. 2014 Sep;55(5):902-11. doi: 10.1093/jrr/rru020. Epub 2014 Apr 11.
2
Tumour control in ion beam radiotherapy with different ions in the presence of hypoxia: an oxygen enhancement ratio model based on the microdosimetric kinetic model.不同离子存在缺氧条件下的离子束放射治疗中的肿瘤控制:基于微剂量动力学模型的氧增强比模型。
Phys Med Biol. 2018 Mar 16;63(6):065012. doi: 10.1088/1361-6560/aa89ae.
3
Radiobiological description of the LET dependence of the cell survival of oxic and anoxic cells irradiated by carbon ions.氧合和乏氧细胞受碳离子照射后细胞存活的 LET 依赖性的放射生物学描述。
J Radiat Res. 2013 Jan;54(1):18-26. doi: 10.1093/jrr/rrs070. Epub 2012 Aug 21.
4
Relative clinical effectiveness of carbon ion radiotherapy: theoretical modelling for H&N tumours.碳离子放射治疗的相对临床疗效:头颈部肿瘤的理论模型
J Radiat Res. 2015 Jul;56(4):639-45. doi: 10.1093/jrr/rrv016. Epub 2015 Apr 8.
5
LET-painting increases tumour control probability in hypoxic tumours.LET 染色提高乏氧肿瘤的肿瘤控制概率。
Acta Oncol. 2014 Jan;53(1):25-32. doi: 10.3109/0284186X.2013.832835. Epub 2013 Sep 10.
6
The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.大分割放疗对缺氧肿瘤亚体积同步剂量增强的影响。
Med Phys. 2006 Nov;33(11):4044-55. doi: 10.1118/1.2358205.
7
Modelling of the oxygen enhancement ratio for ion beam radiation therapy.离子束放射治疗的氧增强比建模。
Phys Med Biol. 2011 Jun 7;56(11):3251-68. doi: 10.1088/0031-9155/56/11/006. Epub 2011 May 4.
8
Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability.立体定向放疗肺部肿瘤的分割治疗:慢性和急性低氧对肿瘤控制概率影响的建模研究。
Radiat Oncol. 2014 Jun 30;9:149. doi: 10.1186/1748-717X-9-149.
9
Evaluation of SCCVII tumor cell survival in clamped and non-clamped solid tumors exposed to carbon-ion beams in comparison to X-rays.评价 SCCVII 肿瘤细胞在夹闭和未夹闭的固体肿瘤中的存活情况,比较其在碳离子束和 X 射线照射下的结果。
Mutat Res. 2013 Aug 30;756(1-2):146-51. doi: 10.1016/j.mrgentox.2013.05.008. Epub 2013 Jun 2.
10
Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.理论分析氧增比的剂量依赖性及其与临床应用的相关性。
Radiat Oncol. 2011 Dec 15;6:171. doi: 10.1186/1748-717X-6-171.

引用本文的文献

1
Intracellular Oxygen Transient Quantification in Vivo During Ultra-High Dose Rate FLASH Radiation Therapy.在超高剂量率 FLASH 放射治疗过程中对体内细胞内氧瞬变的定量分析。
Int J Radiat Oncol Biol Phys. 2024 Nov 1;120(3):884-893. doi: 10.1016/j.ijrobp.2024.04.068. Epub 2024 May 3.
2
A perspective on tumor radiation resistance following high-LET radiation treatment.关于高 LET 射线治疗后肿瘤辐射抗性的观点。
J Cancer Res Clin Oncol. 2024 May 2;150(5):226. doi: 10.1007/s00432-024-05757-8.
3
Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery.

本文引用的文献

1
LET-painting increases tumour control probability in hypoxic tumours.LET 染色提高乏氧肿瘤的肿瘤控制概率。
Acta Oncol. 2014 Jan;53(1):25-32. doi: 10.3109/0284186X.2013.832835. Epub 2013 Sep 10.
2
Influence of chronic hypoxia and radiation quality on cell survival.慢性缺氧和辐射质量对细胞存活的影响。
J Radiat Res. 2013 Jul;54 Suppl 1(Suppl 1):i13-22. doi: 10.1093/jrr/rrs135.
3
Including oxygen enhancement ratio in ion beam treatment planning: model implementation and experimental verification.在离子束治疗计划中包含氧增强比:模型实现与实验验证。
《用于癌症治疗的α粒子发射放射性药物:治疗学发现的生物学基础、现状和未来展望》
Mol Imaging Biol. 2023 Dec;25(6):991-1019. doi: 10.1007/s11307-023-01857-y. Epub 2023 Oct 16.
4
Carbon Ions for Hypoxic Tumors: Are We Making the Most of Them?用于缺氧肿瘤的碳离子:我们是否充分利用了它们?
Cancers (Basel). 2023 Sep 9;15(18):4494. doi: 10.3390/cancers15184494.
5
Combined RBE and OER optimization in proton therapy with FLUKA based on EF5-PET.基于 EF5-PET 的 FLUKA 在质子治疗中联合 RBE 和 OER 优化。
J Appl Clin Med Phys. 2023 Sep;24(9):e14014. doi: 10.1002/acm2.14014. Epub 2023 May 10.
6
DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.基于 DNA 甲基化组的肿瘤缺氧分类器可识别 HPV 阴性头颈部癌患者在接受原发放化疗后的局部区域复发风险。
Clin Cancer Res. 2023 Aug 15;29(16):3051-3064. doi: 10.1158/1078-0432.CCR-22-3790.
7
The 'stealth-bomber' paradigm for deciphering the tumour response to carbon-ion irradiation.解析碳离子照射肿瘤反应的“隐形轰炸机”范式。
Br J Cancer. 2023 Apr;128(8):1429-1438. doi: 10.1038/s41416-022-02117-6. Epub 2023 Jan 13.
8
Perfusion MR prior to radiotherapy is a strong predictor of survival in high-grade gliomas after proton and carbon ion radiotherapy.放疗前的灌注磁共振成像(Perfusion MR)是高级别胶质瘤在质子和碳离子放疗后生存的有力预测指标。
Ann Transl Med. 2022 Nov;10(22):1199. doi: 10.21037/atm-20-1646.
9
Development of a portable hypoxia chamber for ultra-high dose rate laser-driven proton radiobiology applications.用于超高剂量率激光驱动质子放射生物学应用的便携式缺氧舱的研制。
Radiat Oncol. 2022 Apr 15;17(1):77. doi: 10.1186/s13014-022-02024-3.
10
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review.腺样囊性癌碳离子放射治疗的生物学原理与临床证据:一项叙述性综述
Front Oncol. 2021 Nov 30;11:789079. doi: 10.3389/fonc.2021.789079. eCollection 2021.
Phys Med Biol. 2013 Jun 7;58(11):3871-95. doi: 10.1088/0031-9155/58/11/3871. Epub 2013 May 16.
4
Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response.采用扫描碳离子束进行分次碳离子治疗肝癌患者的可行性和临床疗效。
Radiat Oncol. 2013 Mar 13;8:59. doi: 10.1186/1748-717X-8-59.
5
Principal component analysis enhances SNR for dynamic electron paramagnetic resonance oxygen imaging of cycling hypoxia in vivo.主成分分析增强了活体循环缺氧动态电子顺磁共振氧成像的信噪比。
Magn Reson Med. 2014 Jan;71(1):440-50. doi: 10.1002/mrm.24631. Epub 2013 Feb 7.
6
Prostate alpha/beta revisited -- an analysis of clinical results from 14 168 patients.重新审视前列腺的 α/β 受体——14168 例患者的临床结果分析。
Acta Oncol. 2012 Nov;51(8):963-74. doi: 10.3109/0284186X.2012.719635. Epub 2012 Sep 12.
7
Radiobiological description of the LET dependence of the cell survival of oxic and anoxic cells irradiated by carbon ions.氧合和乏氧细胞受碳离子照射后细胞存活的 LET 依赖性的放射生物学描述。
J Radiat Res. 2013 Jan;54(1):18-26. doi: 10.1093/jrr/rrs070. Epub 2012 Aug 21.
8
Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions.碳离子放疗在前列腺癌中晚期超分割方案中的应用:20 至 16 分次。
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):968-72. doi: 10.1016/j.ijrobp.2012.01.072. Epub 2012 Aug 14.
9
Dose prescription and treatment planning based on FMISO-PET hypoxia.基于 FMISO-PET 缺氧的剂量处方和治疗计划。
Acta Oncol. 2012 Feb;51(2):222-30. doi: 10.3109/0284186X.2011.599815. Epub 2011 Aug 28.
10
Accurate description of the cell survival and biological effect at low and high doses and LET's.准确描述低剂量和高剂量以及线性能量传递(LET)下的细胞存活和生物学效应。
J Radiat Res. 2011;52(4):389-407. doi: 10.1269/jrr.10129.